Therapy-resistant lymphomas may want nucleotides, but they just need to grow
Journal of Clinical Investigation · 15.07.2026 · 136 (14)
DOI: 10.1172/jci208384 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2026. Verfasst von Carlos Carmona-Fontaine. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Lymphoma, B-Cell, Nucleotides, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant cells must rapidly synthesize nucleotides to grow and proliferate. Antimetabolite chemotherapies throw a wrench in this process by administering decoy molecules resembling nucleotide precursors that cells cannot use, such as 6-mercaptopurine (6MP) and methotrexate. While this approach remains an essential tool in the treatment of lymphoblastic leukemias and B cell non-Hodgkin lymphomas, approximately 1 in 3 patients will eventually develop therapy-resistant malignancies. In this issue of the JCI , Yang et al. investigated the metabolic adaptations that enable therapy-resistant tumors to grow in the presence of these drugs. Using their previously described mouse model of MYC-driven large B cell lymphoma, they identified that increased expression of the vesicular oligopeptide and histidine transporter SLC15A3 drives dipeptide accumulation in therapy-resistant cells. In lieu of finding other ways to make more nucleotides, these adaptations force cell growth by boosting mTOR signaling. This cunning adaptation, however, is also a vulnerability that can be targeted clinically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Carmona-Fontaine, C. (2026). Therapy-resistant lymphomas may want nucleotides, but they just need to grow. Journal of Clinical Investigation, 136(14). https://doi.org/10.1172/jci208384
Vancouver
Carmona-Fontaine C. Therapy-resistant lymphomas may want nucleotides, but they just need to grow. Journal of Clinical Investigation. 2026;136(14). doi:10.1172/jci208384
BibTeX
@article{CarmonaFontaine2026,
author = {Carmona-Fontaine, Carlos},
title = {Therapy-resistant lymphomas may want nucleotides, but they just need to grow},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {14},
doi = {10.1172/jci208384}
}
EUVIMED